RAPP Rapport Corp: Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan

Simbol resmi perusahaan Rapport Therapeutics (RAPP)

Rapport Therapeutics, Inc. (RAPP) is investing billions into the development of precision neurobiological drugs. Quarterly earnings per share growth illustrates the adaptation of these investments, where -19.00 determines this parameter level. A secure Western legal status protects the company from sanctions, while the RAP platform enables the effective treatment of depression and epilepsy, minimizing harmful side effects for patients.

Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Rapport Therapeutics (RAPP): kanggo periode 08.06.2024 - 16.11.2026

Rincian analitis perusahaan Rapport Therapeutics, Inc.

Analisis fundamental perusahaan:rapportrx.com, RAPP
Produk asil prodhuksi Rapport Corp

Quarterly EPS growth measures the dynamics of net income per share, determining the efficiency of business capitalization. This metric captures the percentage change in earnings, allowing investors to assess a company's resilience to market shocks. By analyzing the quarterly EPS change, one can identify the risk of overpayment or the potential undervaluation of an asset. For Rapport Therapeutics, Inc. (RAPP), this indicator reflects the cost of intensive R&D expenditures required to attract elite neurobiologists. High research and development budgets directly impact the final profitability of each share.

Analisis perusahaan pesaing

JAZZ (Jazz Pharmaceuticals PLC) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Cytokinetics Corp (CYTK) - Wutah bathi EPS kuartalan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan PTC Therapeutics, Inc.|SRRK: Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Centessa Corp (CNTA)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan DYN (Dyne Therapeutics Inc)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Edgewise Pharma EWTX|Alumis Pharma - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|ZVRA - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Contineum Therapeutics, Inc.|LRMR: Wutah bathi EPS kuartalan|Wutah bathi resik saben saham sajroning taun lumaku Capricor Therapeutics CAPR|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan TRDA|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Channel PTHS|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan MediciNova Inc. (MNOV)|SER - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan BTAI (BioXcel Therapeutics Inc)|ProMIS Neurosciences (PMN) - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|Apimeds Pharmaceuticals, Inc. - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan AEON Biopharma, Inc.|NLSP (NLS Pharma) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan BNOX|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan FSD Pharma|Wutah bathi EPS kuartalan Reata